Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Guaranty Bancshares's Ex-Dividend Date Is Friday, Here's What You Need To Know

Thursday marks the last chance for investors to receive the next dividend payout from Guaranty Bancshares (NASDAQ:GNTY).

Benzinga

Hurco Companies's Ex-Dividend Date Is Friday, Here's What You Need To Know

Thursday marks the last chance for investors to receive the next dividend payout from Hurco Companies (NASDAQ:HURC).

Benzinga

Cerner: Dividend Insights

Thursday marks the last chance for investors to receive the next dividend payout from Cerner (NASDAQ:CERN).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Thursday Is Your Last Chance To Buy Great Southern Bancorp Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from Great Southern Bancorp (NASDAQ:GSBC).

Benzinga

Thursday Is Your Last Chance To Buy Independent Bank Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from Independent Bank (NASDAQ:INDB).

Benzinga

5 Value Stocks To Watch In The Consumer Cyclical Sector

What is a Value Stock?

Benzinga

Innate Pharma FY 2021 Earnings Conference Call On March 24, 2022 At 09:00 AM ET

Innate Pharma (NASDAQ:IPHA) will host a conference call at 09:00 AM ET on March 24, 2022, to discuss FY 2021 earnings results.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

$100 Invested In Enterprise Finl Servs 10 Years Ago Would Be Worth This Much

Enterprise Finl Servs (NASDAQ:EFSC) has outperformed the market over the past 10 years by 2.94% on an annualized basis producing an average annual return of 15.18%. Currently, Enterprise Finl Servs has a market capitalization of $1.87 billion.

Benzinga

What Are Whales Doing With JD.com

Someone with a lot of money to spend has taken a bullish stance on JD.com (NASDAQ:JD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

InterCure And Clever Leaves Enter Into International Strategic Partnership

InterCure Ltd.

Benzinga

Cue Health Offers COVID-19 Tests At Albertsons Pharmacies

Cue Health Inc (NASDAQ:HLTH) has partnered with Albertsons Companies Inc (NYSE:ACI) for COVID-19 test kits. The partnership will provide Cue’s molecular COVID-19 tests at participating Albertsons pharmacies across the country. Customers will get their test results delivered to their email in 20 minutes. The companies piloted this in-pharmacy COVID-19 testing program last fall in 40…

Benzinga

Mid-Morning Market Update: Markets Open Higher; Nasdaq Surges Over 1%

U.S. stocks opened on a strong note this morning, with the Nasdaq Composite adding more than 1% on Tuesday.

Benzinga

Here's How Much You Would Have Made Owning Steel Dynamics Stock In The Last 20 Years

Steel Dynamics (NASDAQ:STLD) has outperformed the market over the past 20 years by 9.3% on an annualized basis producing an average annual return of 16.34%. Currently, Steel Dynamics has a market capitalization of $16.47 billion.

Benzinga

What Are Whales Doing With Qualcomm

A whale with a lot of money to spend has taken a noticeably bearish stance on Qualcomm. Looking at options history for Qualcomm (NASDAQ:QCOM) we detected 12 strange trades.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Microsoft Whale Trades For March 22

Someone with a lot of money to spend has taken a bearish stance on Microsoft (NASDAQ:MSFT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

Upgrades

Benzinga

How Is The Market Feeling About Palisade Bio Inc. - Common Stock?

Palisade Bio Inc. - Common Stock's (NASDAQ:PALI) short percent of float has fallen 34.64% since its last report. The company recently reported that it has 116.60 thousand shares sold short, which is 1.0% of all regular shares that are available for trading.

Benzinga

Caribou Biosciences Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q4, Caribou Biosciences (NASDAQ:CRBU) posted sales of $2.56 million. Earnings were up 11.9%, but Caribou Biosciences still reported an overall loss of $18.48 million.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Strata Skin Sciences's Return On Capital Employed Insights

Strata Skin Sciences (NASDAQ:SSKN) brought in sales totaling $9.06 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 62.96%, resulting in a loss of $849.00 thousand.

Benzinga

UroGen Pharma's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q4, UroGen Pharma's (NASDAQ:URGN) reported sales totaled $16.17 million. Despite a 5.82% increase in earnings, the company posted a loss of $28.45 million.

Benzinga

Here's Why BTIG Is Bullish On Datadog

BTIG analyst Gray Powell initiated coverage of Datadog Inc (NASDAQ:DDOG) with a Buy rating and $175 price target (24.9% upside). Powell saw the observability market benefiting over the next few years as companies increasingly invest in digital transformation initiatives. Powell saw Datadog "winning across multiple product categories." Powell's checks indicate Datadog as the most innovative…

Benzinga

Helbiz Media Inks Deal To Distribute Helbiz Live On Amazon Video In Italy

Helbiz Inc's (NASDAQ:HLBZ) Helbiz Live will be available on Amazon.Com Inc (NASDAQ:AMZN) Amazon Prime Video Channels on April 2, after the recent completion of technology integration. Helbiz Media and Amazon Prime Video have signed an agreement to distribute Helbiz Live on Amazon Video in Italy. HelbizLive is Italy's new live sports streaming service and home of…

Benzinga

Bernstein Explains How Apple Could Produce $10B In Incremental Revenue

Bernstein analyst Toni Sacconaghi acknowledged that Apple Inc (NASDAQ: AAPL) had quietly built a small but growing ad business. However, Sacconaghi estimated that Apple's ad revenue was well under 2% of its overall revenue.

Benzinga

Adamis Pharma Recalls Allergy Treatment Symjepi For Potential Manufacturing Defect

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) voluntarily recalls certain lots of Symjepi (epinephrine) Injection 0.15 mg and 0.3 mg pre-filled single-dose syringes to the consumer level. The batches are being recalled due to the potential clogging of the needle preventing the dispensing of epinephrine. US WorldMeds (USWM) exclusively markets and distributes Symjepi in the U.S.,…

Benzinga

Why Okta Shares Are Tumbling Today

Okta Inc (NASDAQ: OKTA) shares are trading lower Tuesday morning following several reports indicating the company is investigating a digital breach.

1 … 789 790 791 792

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.